Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Notes Payable, Noncurrent

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Notes Payable, Noncurrent

Citius Pharmaceuticals, Inc. (CTXR) had Notes Payable, Noncurrent of $6.41 million as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent

us-gaap:LongTermNotesPayable · last filed 2026-08-14

  • 2026-06-30: Notes Payable, Noncurrent $6.41M.
  • 2021-03-31: Notes Payable, Noncurrent $164.58K.
  • 2020-12-31: Notes Payable, Noncurrent $164.58K.
  • 2020-09-30: Notes Payable, Noncurrent $164.58K.
Period endNotes Payable, Noncurrent
2026-06-30$6.41M
10-Q · filed 2026-08-14
2021-03-31$164.58K
10-Q · filed 2021-05-13
2020-12-31$164.58K
10-Q · filed 2021-02-11
2020-09-30$164.58K
10-K · filed 2021-12-15
2020-06-30$164.58K
10-Q · filed 2020-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36